Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"DPT0O3T46P"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Balar%2C+Arjun+V%22&type=Person&filter%5B%5D=topic_facet%3A%22DPT0O3T46P%22
/vufind/Search/Results?lookfor=%22Balar%2C+Arjun+V%22&type=Person&filter%5B%5D=topic_facet%3A%22DPT0O3T46P%22
Search /vufind/Search2/Results?lookfor=%22Balar%2C+Arjun+V%22&type=Person&filter%5B%5D=topic_facet%3A%22DPT0O3T46P%22
PubPharm (8)
1
Putative Biomarkers of Clinical Benefit With Pembrolizumab in Advanced Urothelial Cancer : Results from the KEYNOTE-045 and KEYNOTE-052 Landmark Trials
enthalten in:
Clinical cancer research : an official journal of the American Association for Cancer Research
| 2022
von
Bellmunt, J.
|
de Wit, R.
|
Fradet, Y.
| +28
CommentIn: J Urol. 2023 May;209(5):1025-1026. - PMID 37026649
Wird geladen...
2
Pembrolizumab monotherapy for high-risk, non-muscle invasive bladder cancer - Authors' reply
enthalten in:
The Lancet. Oncology
| 2021
von
Balar, A.
|
Kamat, A.
|
de Wit, R.
| +1
CommentOn: Lancet Oncol. 2021 Jul;22(7):919-930. - PMID 34051177
Wird geladen...
3
Pembrolizumab monotherapy for the treatment of high-risk non-muscle-invasive bladder cancer unresponsive to BCG (KEYNOTE-057) : an open-label, single-arm, multicentre, phase 2 study
enthalten in:
The Lancet. Oncology
| 2021
von
Balar, A.
|
Kamat, A.
|
Kulkarni, G.
| +15
CommentIn: Nat Rev Urol. 2021 Oct;18(10):577-578. - PMID 34230659
Wird geladen...
4
Long-Term Outcomes in KEYNOTE-052 : Phase II Study Investigating First-Line Pembrolizumab in Cisplatin-Ineligible Patients With Locally Advanced or Metastatic Urothelial Cancer
enthalten in:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
| 2020
von
Vuky, J.
|
Balar, A.
|
Castellano, D.
| +13
Wird geladen...
5
Outcomes With First-line PD-1/PD-L1 Inhibition in Advanced Urothelial Cancer : A Single Institution Experience
enthalten in:
Clinical genitourinary cancer
| 2020
von
Hsu, M.
|
Xia, Y.
|
Troxel, A.
| +5
Wird geladen...
6
Pembrolizumab as First-line Therapy in Cisplatin-ineligible Advanced Urothelial Cancer (KEYNOTE-052) : Outcomes in Older Patients by Age and Performance Status
enthalten in:
European urology oncology
| 2020
von
Grivas, P.
|
Plimack, E.
|
Balar, A.
| +11
Wird geladen...
7
Recent Clinical Trials Explore Immunotherapies for Urothelial Carcinoma
enthalten in:
Oncology (Williston Park, N.Y.)
| 2019
von
Balar, A.
Wird geladen...
8
First-line pembrolizumab in cisplatin-ineligible patients with locally advanced and unresectable or metastatic urothelial cancer (KEYNOTE-052) : a multicentre, single-arm, phase 2 study
enthalten in:
The Lancet. Oncology
| 2017
von
Balar, A.
|
Castellano, D.
|
O'Donnell, P.
| +12
CommentIn: Lancet Oncol. 2017 Nov;18(11):1428-1430. - PMID 28967486
Wird geladen...
1
[1]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Thema: DPT0O3T46P
Medienart
8
Aufsätze
7
E-Artikel
7
E-Ressourcen
1
Gedruckte Aufsätze
Zeitschriftentitel
3
The Lancet. Oncology
1
Clinical cancer research : an official journal ...
1
Clinical genitourinary cancer
1
European urology oncology
1
Journal of clinical oncology : official journal...
1
Oncology (Williston Park, N.Y.)
Alle anzeigen ...
weniger ...
Thema
8
Antibodies, Monoclonal, Humanized
DPT0O3T46P
8
pembrolizumab
7
Journal Article
5
Antineoplastic Agents, Immunological
5
Research Support, Non-U.S. Gov't
4
B7-H1 Antigen
4
Clinical Trial, Phase II
3
Cisplatin
3
Multicenter Study
3
Q20Q21Q62J
2
52CMI0WC3Y
2
Bladder cancer
2
CD274 protein, human
2
Immunotherapy
2
Programmed Cell Death 1 Receptor
2
Randomized Controlled Trial
2
atezolizumab
1
31YO63LBSN
1
3WJQ0SDW1A
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
6
2020-
2
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
8
Englisch
Haven't found what you're looking for?
Wird geladen...